BD 10mL Syringe Luer-Lok Tip Catalog number 301997 The BD Single Use, Hypodermic Syringe is intended for use by health care professionals for general purpose fluid aspiration/injection
Published July 26, 2017 · Recall initiated: September 16, 2016
Summary
FDA records medical device Class II recall Z-2752-2017, published July 26, 2017 and initiated September 16, 2016. Recalling firm: Becton Dickinson & Company; Status: Terminated; Reported quantity: 547,600 units; Lot: 6061746 2021-02 6082982 2021-02 6089821 2021-03 6117858 2021-04 6117863 2021-04 6117889 2021-04 6117891 2021-04 6146962 2021-04 6173697 2021-05 6173767 2021-06 6173779 2021-06 6208614 2021-07. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
BD identified that several lots did not receive the specified dose of irradiation necessary to meet the Sterility Assurance Level (SAL) required.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Becton Dickinson & Company
- Distributor
- Nationwide Distribution
- Lot
- 6061746 2021-02 6082982 2021-02 6089821 2021-03 6117858 2021-04 6117863 2021-04 6117889 2021-04 6117891 2021-04 6146962 2021-04 6173697 2021-05 6173767 2021-06 6173779 2021-06 6208614 2021-07
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDABD®Spinal Tray with BD®Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Quincke Needle 26 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Whitacre Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 2 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD 3ml Syringe Luer-Lok" Tip Catalog 309657 The BD Single Use, Hypodermic Syringe is intended for use byJuly 26, 2017
- FDAMerge Eye Care PACS Viewer 5.2 Merge Eye Care PACS is a software solution for the display, management,July 26, 2017
Questions about this recall
Was BD 10mL Syringe Luer-Lok Tip Catalog number 301997 The BD Single Use, Hypodermic Syringe is intended for use by health care professionals for general purpose fluid aspiration/injection recalled?
Yes. FDA published recall Z-2752-2017 on July 26, 2017. Reported hazard: BD identified that several lots did not receive the specified dose of irradiation necessary to meet the Sterility Assurance Level (SAL) required.
What should I do if I have this product?
Voluntary: Firm initiated · Letter